Background and Aims: Patients in whom neutropenia recovery is complicated by pneumonia have an increased risk of acute lung injury (ALI) and detrimental outcomes. The aim of the present study was to investigate whether inhibition of neutrophil elastase (NE) is effective in lipopolysaccharide (LPS)-induced ALI during neutropenia recovery in a murine model, and whether it upregulates the activation of the MerTK signalling pathway.
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Methods: Cyclophosphamide was given to mice to induce neutropenia. Seven days later, they were administered LPS by intratracheal instillation. Sivelestat, a neutrophil elastase inhibitor, was given by intraperitoneal injection once daily starting on day 0 and continuing until mice were sacrificed on day 5 (preventive group). Alternatively, sivelestat was given after, instead of before, LPS administration on day 2 (therapeutic group).
Results: Sivelestat attenuated the lung oedema and histopathological changes associated with LPS-induced lung injury. The accumulation of neutrophils and the concentrations of TNF-α, IL-6, and MPO in bronchoalveolar lavage (BAL) fluids were inhibited effectively by sivelestat. The expression of ICAM-1 and NF-κB p65 was also reduced after sivelestat administration. The protein and gene expression of MerTK tended to increase with sivelestat treatment.
Conclusion:
Sivelestat significantly attenuated LPS induced ALI during recovery from neutropenia, and this effect was associated with MerTK induction. These findings suggest that NE inhibition could be a promising means of alleviating lung inflammation without increasing susceptibility to infection in ALI/ARDS during neutropenia recovery. Background and Aims: Autophagy is a highly conserved selfdegradative process which balance sources of energy in many physiological conditions. Chronic obstructive pulmonary disease (COPD) is a progressive life-threatening disease caused mainly by cigarette smoking.
LABA/LAMA combination significantly ameliorate the decline in lung function in patient with COPD. Recently, several evidences suggest that increased autophagy contributes to COPD pathogenesis. Moreover, the effect of muscarinic receptor antagonists and β2-agonists on regulating autophagy have been documented. We hypothesis that autophagy may be a potential novel target for dual bronchodilator treatment in an in vitro model that mimics COPD.
Methods: BEAS-2B human bronchial epithelial cells were pre-treated with olodaterol/tiotropium or indacaterol/glycopyrrolate followed by exposure to cigarette smoke extract for 6 h. Autophagy was determined by flow cytometry, acridine orange staining and western blot. MTT assay, Annexin V assay and propidium iodide staining were used to evaluate cell death, apoptosis and cell cycle arrest. Oxidative stress were performed by flow cytometry, DCFDA staining. Statistical analyses were performed using GraphPad Prism. P-values ≤ 0.05 were considered significant.
Results: Olodaterol/tiotropium or indacaterol/glycopyrrolate treatment decreased formation of AVO (lysosomes and autophagolysosomes), the ratio of LC3-II/LC3-I and Beclin1 expression without affecting apoptosis and cell cycle progression in BEAS-2B cells stimulated with CSE. Moreover, olodaterol/tiotropium and indacaterol/glycopyrrolate treatment reversed CSE-induced cell death, respectively. Oxidative stress is a major inducer of autophagy. In our finding, olodaterol/tiotropium and indacaterol/ glycopyrrolate both decrease intracellular ROS level in BEAS-2B cells stimulated with CSE. In comparison, indacaterol/glycopyrrolate combination has a stronger inhibitory effect on autophagy and oxidative stress than olodaterol/tiotropium.
These data provide a novel evidence that dual bronchodilator retards bronchial epithelial cells death through regulating autophagy via inhibiting oxidative stress in BEAS-2B cells stimulated with CSE, which suggest that autophagy may be a potential novel mechanism of the action of dual bronchodilator treatment in COPD. Background and Aims: Neutrophil elastase (NE) is known to cause airway inflammation and plays a pivotal role in pathogenesis of COPD. It has been reported that sphingolipid including sphingosine 1-phosphate 1 inhibitor (SK1-I) (5 mg/kg in PBS) was administered intranasally into C57BL/6 mice 1 h before NE administration. Bronchoalveolar lavage fluid (BALF) and lung sections were analyzed on day 11. We measured total cell counts and S1P secretion in BALF. We also evaluated the effect of SK1-I on airway inflammation and goblet cells by determining the Alcian blue/PAS-positive area in lung sections (evaluated by a semiautomatic imaging system, WinROOF ® (Mitani corporation, Japan)).
Results: NE increased total cell number (9.3 AE .75×10-4 vs 51.5 AE 1.1×10-4 per mL, P < 0.01) and neutrophil count (0.0 AE .04×10 − 4 vs 34. AE 2.7 × 10 − 4 per mL, P < 0.001) in BALF, and induced airway goblet cell hyperplasia. NE also increased S1P secretion (P < 0.05) in BALF. Treatment with SK1-I inhibited NE-induced increase of total cell numbers (13. AE .73×10-4 per mL, P < 0.05), neutrophil count (2.6 AE .28×10-4 per mL, P < 0.01), and KC (P < 0.01) in BALF. SK1-I attenuated NE-induced goblet cell hyperplasia.
Conclusion: Inhibiting SphK1 caused significant reduction in NE-
induced neutrophilic airway inflammation and goblet cell hyperplasia in mice. Our results suggest that the inhibition of S1P signalling could be a new therapeutic strategy for COPD. Flos Magnoliae (FM, Chinese name: Xin-yi) is an oriental medicinal herb commonly used for symptomatic relief of upper airway disease. In this study, we examined the effects of FM extract and its chemical constituents on the modulation of ANO1 channels to evaluate for use in therapeutic agents for treatment of asthma.
Methods: A 30% ethanolic extract of FM was prepared. Human ANO1 over-expressed HEK293T cells were treated with FM extract or its five chemical constituents. Modulation of ANO1 activity was measured by using a conventional whole-cell patch-clamp technique.
Results: We revealed that FM EtOH (30, 100, and 300 μg/mL) and its chemical constituent tiliroside inhibited ANO1 activity in ANO1-overexpressing HEK293T cells. In addition, we showed that the treatment of airway epithelial cell line Calu-3 with interleukin-4 significantly increased ANO1 current (I ANO1 ), but not cystic fibrosis transmembrane conductance regulator (CFTR)-mediated chloride current (I CFTR ). FMEtOH and tiliroside specifically modulated I ANO1 .
Conclusion:
Our results suggest that FM extract and its chemical constituent, tiliroside, may have a therapeutic potential for respiratory inflammatory disease through modulating the activities of ANO1. Aim: To establish the role of mediators of the immune, endocannabinoid, lipoxygenase and nitroxidergic systems in the regulation of inflammation in moderate and severe COPD and controlled asthma.
Methods: Flow cytometry, gas-liquid chromatography, enzyme immunoassay.
Results: A commonality of immune disorders in COPD and asthma has found. It has revealed that T helper (Th) immune response depending on the disease severity or the disease control is multi-type. The mixed phenotypes appear and it is followed by development Th17 type of immune response associated with the disease progression. The common mechanisms of maintenance of systemic inflammation also include a decrease in the expression of cannabinoid receptors type 2 (CB2), an increase in the synthesis of nitric oxide, a hyperproduction of cytotoxic eicosanoids that is a result of metabolic changes in fatty acids (FA), an imbalance between their pro-and antiinflammatory oxy derivatives. The substantial reorganization of FA composition of mitochondrial membrane is a sign of mitochondrial dysfunction determining the formation of the hypoxia. The endocannabinoid system and its receptors play a special role in the inflammation control. The increased CB2 expression contributes keeping the balance between pro-and antiinflammatory mediators under normal conditions. Inhibition of CB2 expression induces limiting the function of endocannabinoid system, which leads to the immune system activation. The correlation between the level of nitric oxide and the pathological process severity indicate that the dysfunction of nitroxidergic system make a contribution to the development of the respiratory diseases.
The obtained knowledge broadens our understanding of the etiopathogenesis of respiratory diseases and also can explain the key mechanisms of the development of extrapulmonary pathology induced by the chronic inflammatory process. Background and Aims: Ventilator induced lung injury (VILI) confers significant sequelae of mechanical ventilation in critical care, and lung protection strategy had been developed. However, the impact of obesity on ventilator induced lung injury is not fully understood. One recent search found fat-fed mice significantly attenuated ventilator-induced lung injury. Alevolar macrophages (AMs) is known to be pivotal in initiating acute lung injury. In the present study, we supposed that the obesity may affect the polarization of AMs and subsequent development of acute lung injury.
